companydata.dkcompanydata.dk

ABBOTT LABORATORIES A/S: Financial statements 2023

CVR: 31528615

Source: annual report 2023, Danish Business Authority

01/01/2023 – 31/12/2023

ABBOTT LABORATORIES A/S (CVR 31528615) has filed annual accounts for 2023. In 2023, the company reported revenue of DKK 327,403,961 and a net result of DKK 9,168,013 compared with DKK 6,098,000 the year before. That is an increase of 22.1% compared with the year before. The profit margin was 2.8%. Equity in the 2023 report amounted to DKK 132,955,513. The solvency ratio was 60.9%. The company had 50 employees in the financial year.

Revenue
DKK 327,403,961
Gross Profit
DKK 62,597,880
Profit/Loss
DKK 9,168,013
Equity
DKK 132,955,513
Total Assets
DKK 218,289,331
Employees
50

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2023327.4 mio.62.6 mio.9.2 mio.133 mio.50
2022268.1 mio.51.2 mio.6.1 mio.123.8 mio.44
2021259.2 mio.44.2 mio.6 mio.117.7 mio.39
2020195.9 mio.39.7 mio.4.8 mio.111.7 mio.36
2019162.9 mio.39.8 mio.6 mio.106.9 mio.36

Official annual report

View the official annual report directly on the page with a Pro subscription.

Fetch this data via API

Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.

See the API documentation

Events in 2023

Registered as owner of ABBOTT LABORATORIES A/SDec 15, 2023

As of December 15, 2023, is registered as an owner of ABBOTT LABORATORIES A/S with an ownership share of 100%.

ABBOTT LABORATORIES A/S: The 2022 annual report is outJun 28, 2023

ABBOTT LABORATORIES A/S has published its annual report for 2022. Revenue came to DKK 268,116,000, and the net result was DKK 6,098,000.

Karl Andreas Almroth joins the board of ABBOTT LABORATORIES A/SMar 1, 2023

As of March 1, 2023, Karl Andreas Almroth has joined the board of directors of ABBOTT LABORATORIES A/S.

Ole Martin Alfstad Christiansen leaves the board of ABBOTT LABORATORIES A/SMar 1, 2023

As of March 1, 2023, Ole Martin Alfstad Christiansen has left the board of directors of ABBOTT LABORATORIES A/S.

Karl Andreas Almroth joins ABBOTT LABORATORIES A/S as adm. dir.Mar 1, 2023

As of March 1, 2023, Karl Andreas Almroth is registered as adm. dir. of ABBOTT LABORATORIES A/S.

Ole Martin Alfstad Christiansen steps down as adm. dir. of ABBOTT LABORATORIES A/SMar 1, 2023

As of March 1, 2023, Ole Martin Alfstad Christiansen has stepped down as adm. dir. of ABBOTT LABORATORIES A/S.

About ABBOTT LABORATORIES A/S

ABBOTT LABORATORIES A/S is a Danish company of the type Aktieselskab based in København S, founded in 1971. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The management consists of Karl Andreas Almroth. The board consists of Bradley Jay Slater (chair), Fredrik Björn Anders Björnulfson and Karl Andreas Almroth. The company is owned by ABBOTT MEDICAL OVERSEAS CYPRUS LIMITED. The company has 48 employees (2026). In 2025, the company reported revenue of DKK 412,831,732 and a net result of DKK 63,142,932 compared with DKK 8,276,415 the year before. Equity in the 2025 report amounted to DKK 74,374,860.

Source: annual report 2025, Danish Business Authority